A self-administered device to collect blood yields high-quality antibody samples and works successfully in a high proportion of users, according… Read More
The U.S. Food and Drug Administration has approved Impel NeuroPharma’s Trudhesa to treat migraine headaches, the Seattle company announced Friday.… Read More
Edmond Fischer, Nobel Laureate and emeritus professor at the University of Washington biochemistry department, died peacefully in Seattle on Aug.… Read More
Visus Therapeutics, a Seattle-based startup developing a presbyopia-correcting eye drop, raised $20 million. The fresh cash comes just six months… Read More
Seattle and South San-Francisco based preclinical biotech company Sonoma Biotherapeutics has raised $265 million in new funding, the company announced… Read More
National telehealth provider Amwell said it will acquire Portland, Ore.-based healthtech startup Conversa and SilverCloud Health. Conversa, founded in 2014,… Read More
AdaptX, a Seattle-based startup started by an anesthesiologist seeking to improve patient care with better insights from healthcare data, raised… Read More
Eliem Therapeutics, a clinical stage biotech company generating therapies for pain, depression and other nervous-system related conditions, has filed to… Read More
Shape Therapeutics, a Seattle preclinical stage biotech company developing RNA editing and gene therapy technologies, has raised $112 million. The… Read More
